CSIMarket



HOSPIRA, INC.  (HSP)
Other Ticker:  
 
 

HSP's Operating Income Growth by Quarter and Year

Hospira,'s Operating Income results by quarter and year




HSP Operating Income (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
IV Quarter December - 53.20 30.80 -212.30
III Quarter September 227.50 29.80 -16.50 -85.20
II Quarter June 99.50 52.20 -2.20 190.50
I Quarter March 99.60 -118.60 46.70 163.80
FY   426.60 16.60 58.80 56.80



HSP Operating Income third quarter 2014 Y/Y Growth Comment
HOSPIRA, INC. achieved in the third quarter 2014, above Company average Operating Income surge of 663.42% year on year, to $ 227.50 millions.

Looking into third quarter 2014 results within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income growth. While Hospira, Inc.' s Operating Income doubling of 663.42% ranks overall at the positon no. 99 in the third quarter 2014.

Explain Operating Income growth


HSP Operating Income ( Y/Y Growth %) 2014
2013 2012 2011
IV Quarter December - 72.73 % - -
III Quarter September 663.42 % - - -
II Quarter June 90.61 % - - 63.8 %
I Quarter March - - -71.49 % -21.1 %
FY   - -71.77 % 3.52 % -89.06 %

Financial Statements
Hospira,'s third quarter 2014 Operating Income $ 227.50 millions HSP's Income Statement
Hospira,'s third quarter 2013 Operating Income $ 29.80 millions Quarterly HSP's Income Statement
New: More HSP's historic Operating Income Growth >>


HSP Operating Income (Quarter on Quarter Growth %)

2014
2013 2012 2011
IV Quarter December - 78.52 % - -
III Quarter September 128.64 % -42.91 % - -
II Quarter June -0.1 % - - 16.3 %
I Quarter March 87.22 % - - 205.6 %
FY (Year on Year)   - -71.77 % 3.52 % -89.06 %




Operating Income third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #10
Overall #99

Operating Income Y/Y Growth Statistics
High Average Low
1314.46 % 46.22 % -82.4 %
(March 31, 2014)   (Dec. 30. 2011)
Operating Income third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #10
Overall #99
Operating Income Y/Y Growth Statistics
High Average Low
1314.46 % 46.22 % -82.4 %
(March 31, 2014)   (Dec. 30. 2011)

Operating Income by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Hospira,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
370.57 % 31.82 % -80.46 %
(June 30, 2007)  


HSP's III. Quarter Q/Q Operating Income Comment
HOSPIRA, INC. achieved in the III. Quarter 2014 above company average sequential Operating Income doubling of 128.64%, to $ 227.50 millions, from $99.50 millions in the second quarter.
HSP is going from strength to strength, not just reporting above average increase, and additionally improving pace, Miguel Carter, Healthcare sector observer allocated in Dallas added.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Operating Income quarter on quarter growth. While Hospira,'s Operating Income growth quarter on quarter, overall rank is 200.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #11
Overall #200
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #11
Overall #200
Operating Income Q/Q Growth Statistics
High Average Low
370.57 % 31.82 % -80.46 %
(June 30, 2007)  


HSP's III. Quarter Q/Q Operating Income Comment
HOSPIRA, INC. achieved in the III. Quarter 2014 above company average sequential Operating Income doubling of 128.64%, to $ 227.50 millions, from $99.50 millions in the second quarter.
HSP is undergoing a remarkable growth, with reporting better then average growth, but also increasing rate, Miguel Carter, Healthcare sector observer allocated in Dallas said.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Operating Income quarter on quarter growth. While Hospira,'s Operating Income growth quarter on quarter, overall rank is 200.


Hospira,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep. 30, 2014)
12 Months Ending
(June 30. 2014)
12 Months Ending
(March 31, 2014)
12 Months Ending
(Dec 31 2013)
12 Months Ending
(Sep. 30, 2013)
Cumulative Operating Income 12 Months Ending $ 479.80 $ 282.10 $ 234.80 $ 16.60 $ -5.80
Y / Y Operating Income Growth (TTM) - - - -71.77 % -
Year on Year Operating Income Growth Overall Ranking # # # # 1327 #
Seqeuential Operating Income Change (TTM) 70.08 % 20.14 % 1314.46 % - -
Seq. Operating Income Growth (TTM) Overall Ranking # 99 # 139 # 139 # 0 # 0




Cumulative Operating Income growth Comment
Hospira, saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 663.42% year on year, to $ 480 millions if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months Operating Income growth was higher than company's average 0.35% and higher than % growth in June 30. 2014. And, Hospira, realized the fastest Operating Income growth, in Major Pharmaceutical Preparations industry.
But sequential rise was slower at 70.08 % from $282.1 millions recorded in the period from June 30. 2014 to Sep. 30, 2013 Miguel Carter went on.
Yet it was evidence of strength, as the average Q/Q TTM growth stands at 46.22%. In the Sep. 30, 2014 period, Hospira, had cumulative twelve months Operating Income of $ 480 millions compare to Operating Loss of $ -6 millions a year ago.
Not only that Major Pharmaceutical Preparations company has regained the bottom-line, it is already gaining momentum and showing above average Operating Income gain, from the twelve months ending in the quarter before of 70.08 % from $282.1 millions.

HOSPIRA, INC. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
1314.46 %
46.22 %
-82.4 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Operating Income TTM Y/Y Growth Statistics
High Average Low
91.78 %
0.35 %
-89.06 %
(June 30, 2008)  


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 10
S&P 500 # 99
Cumulative Operating Income growth Comment
Hospira, saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 663.42% year on year, to $ 480 millions if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months Operating Income growth was higher than company's average 0.35% and higher than % growth in June 30. 2014. And, Hospira, realized the fastest Operating Income growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended June 30. 2014 rise was less at 70.08 % from $282.1 millions reported in twelve months ending a quarter before.
Still it was evidence of strength, while the average sequential Operating Income advancement stands at 46.22%.
The growth was much higher sequentially exhibited at 70.08 % jump from $282.1 millions in twelve months ending a quarter June 30. 2014. In the Sep. 30, 2014 period, Hospira, had cumulative twelve months Operating Income of $ 480 millions compare to Operating Loss of $ -6 millions a year ago.
Even more so, not just that Hospira, has regained the profitability, Hospira, by this time is improving fast and showing better then average Operating Income rise, from the twelve months ending in the quarter June 30. 2014 of 70.08 % from $282.1 millions.

HOSPIRA, INC. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
1314.46 %
46.22 %
-82.4 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Operating Income TTM Y/Y Growth Statistics
High Average Low
91.78 %
0.35 %
-89.06 %
(June 30, 2008)  


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 10
S&P 500 # 99




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
HSP's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for HSP's Competitors
Operating Income Growth for Hospira,'s Suppliers
Operating Income Growth for HSP's Customers

You may also want to know
HSP's Annual Growth Rates HSP's Profitability Ratios HSP's Asset Turnover Ratio HSP's Dividend Growth
HSP's Roe HSP's Valuation Ratios HSP's Financial Strength Ratios HSP's Dividend Payout Ratio
HSP's Roa HSP's Inventory Turnover Ratio HSP's Growth Rates HSP's Dividend Comparisons



Companies with similar Operating Income doubling for the quarter ending Sep. 30, 2014 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep. 30, 2014
Ani Pharmaceuticals inc911.86%$ 911.859 millions
HOSPIRA, INC.663.42%$ 663.423 millions
Becton Dickinson And Company427.63%$ 427.632 millions
Heska Corporation354.67%$ 354.667 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NLO's Profile

Stock Price

NLO's Financials

Business Description

Fundamentals

Charts & Quotes

NLO's News

Suppliers

NLO's Competitors

Customers & Markets

Economic Indicators

NLO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071